Median Diagnostics Inc.
Founded in 1999 and listed on KONEX in 2017, Median Diagnostics develops and manufactures immunoassay, molecular, and point-of-care in vitro diagnostic kits for animal diseases.
Price
Change
Market cap
Business overview
Source: DART corporate disclosureMedian Diagnostics Inc. was founded in 1999 and listed on the KONEX market in 2017, specializing in in vitro diagnostics (IVD) for animal diseases. The company develops, manufactures, and sells animal diagnostic kits for cattle, swine, and poultry along with Biologicals raw materials, using immunoassay (ELISA), molecular diagnostics (PCR, Real-time RT-PCR, DNA Chip), and point-of-care testing (POCT, Rapid Kit) technologies, including products such as the VDRG BVDV Ag Rapid Kit. In fiscal 2025, revenue reached KRW 11,969 million, with ELISA immunoassay kits accounting for about 42.8% and PCR molecular diagnostics for about 27.3%.
Products & technology
- ELISA for Bovine/Swine/PoultryEnzyme immunoassay-based diagnosis for cattle, swine, poultry
- PCR & RT-PCR kit / Real-time RT-PCR kitGene amplification diagnostics for animals and humans
- DNA Chip kitMolecular diagnostics
- Companion Animals / Livestock & Poultry Rapid kitRapid point-of-care testing for companion animals, livestock, poultry
- Covid19 ab/ag Rapid kitRapid antigen/antibody testing for humans
- VDRG BVDV Ag Rapid KitRapid antigen diagnosis of bovine viral diarrhea (BVDV)
- Bovine pregnancy diagnosis kitDiagnosis of bovine pregnancy
Regulatory approvals
data.go.kr12 Korean MFDS device approvals · 2020–2024
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2024-04-01Product approval · Class 3체외 제허 24-225 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2022-04-12Product approval · Class 3체외 제허 22-240 호
- MFDSIVD reagent for infectious disease, immunological method2022-02-15Product approval · Class 3체외 제허 22-105 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological methodRevoked2020-11-12Product approval · Class 3체외 제허 20-960 호
- MFDSSpecimen transport mediaRevoked2020-08-24Product approval · Class 1체외 제신 20-1269 호
- MFDSSpecimen transport mediaRevoked2020-08-13Product approval · Class 1체외 제신 20-1217 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2020-07-16Product approval · Class 3체외 제허 20-580 호
- MFDSIVD reagents for extracting nucleic acidsRevoked2020-06-01Product approval · Class 1체외 제신 20-740 호
- MFDSSpecimen transport mediaRevoked2020-05-20Product approval · Class 1체외 제신 20-685 호
- MFDSTool for specimensRevoked2020-05-08Product approval · Class 1제신 20-616 호
- MFDSTool for specimensRevoked2020-05-08Product approval · Class 1제신 20-615 호
- MFDSIVD reagents for extracting nucleic acidsRevoked2020-05-04Product approval · Class 1제신 20-596 호
R&D and key agreements
Source: DART corporate disclosureASFV DIVA 백신 개발 · 아프리카돼지열병(ASFV) · New vaccine development pursued
반려동물 암 12종 다중 qPCR 키트 개발 · 반려동물 암 12종 · Multiplex qPCR-based cancer diagnostic kit development
유전자 가위 기반 POCT 진단키트 개발 · Gene-editing-based point-of-care testing kit development
Companies approved for the same productsMedical Devices
Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.
KOSDAQ-listed IVD company using SG Cap™ multiplex diagnostic technology for infectious disease, cancer, and companion animal testing.
KOSPI-listed in-vitro diagnostics company known for the STANDARD Q antigen/antibody test kits.
KOSDAQ-listed point-of-care immunodiagnostics company supplying diagnostic cartridges and the ichroma/AFIAS instrument series.
Holds manufacturing approvals for 42 point-of-care diagnostic reagents and devices in the IVD market.
GC Medical Science Corporation, KOSDAQ-listed since 2014, operates diagnostic reagent, blood glucose, and hemodialysis solution businesses.
Founded 1996, listed on KOSDAQ in 2024, OSANG HEALTHCARE develops and sells biochemistry, immunodiagnostic, and molecular IVD products.
KOSDAQ-listed in-vitro diagnostics company developing the LabChip-based VERI-Q molecular diagnostic device series.
Bioneer, founded in 1992 and KOSDAQ-listed in 2005, provides gene analysis equipment, molecular diagnostics, and RNAi drug development.
KOSDAQ-listed IVD company producing COVID-19 and HIV point-of-care diagnostic reagents alongside rubber products and entertainment businesses.
Founded in 1987 and listed on KOSDAQ in 2000, NanoenTek develops Lab-On-a-Chip in-vitro diagnostic devices and life science instruments.
KOSDAQ-listed IVD company producing time-resolved fluorescence immunodiagnostic products under the Exdia TRF brand.
Founded in 2011 and KOSDAQ-listed in 2019, Sugentech develops multiplex immunoblot, point-of-care, and digital healthcare diagnostics.
Sources and updates
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- AI visibility
- Measured 2026-08-13
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition